News Roche under pressure as second rituximab biosimilar filed in... Sandoz is following closely behind rival from Teva and Celltrion.
News Mylan/Biocon Herceptin biosimilar faces EU delay EU inspectors require re-inspection of Bangalore plant.
News Genentech's subcutaneous rituximab approved in US Subcutaneous version gives more convenient injection lasting minutes, rather than several hours.
News UK watchdog says MSD may have blocked Remicade biosimilars MSD may have abused dominant market position, says CMA.
News J&J's Remicade faces further biosimilar competition in US FDA approves Samsung Bioepis biosimilar.
News Mylan expects first US Herceptin biosimilar launch Deal with Roche paves way for near-copy of breast cancer blockbuster
News Novo sues Lilly over 'misleading' GLP-1 ad campaigning The rivalry between Novo Nordisk and Eli Lilly in the GLP-1 market has spilled over into the courts in the US, with claims of misleading advertising.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
